SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-012368
Filing Date
2018-08-20
Accepted
2018-08-20 17:06:53
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 802145
2 ex10-4.htm EX-10.4 16080
3 ex31-1.htm EX-31.1 19287
4 ex31-2.htm EX-31.2 19298
5 ex32-1.htm EX-32.1 8372
6 ex32-2.htm EX-32.2 8649
  Complete submission text file 0001493152-18-012368.txt   3673965

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE prph-20180630.xml EX-101.INS 534389
8 XBRL SCHEMA FILE prph-20180630.xsd EX-101.SCH 49417
9 XBRL CALCULATION FILE prph-20180630_cal.xml EX-101.CAL 59603
10 XBRL DEFINITION FILE prph-20180630_def.xml EX-101.DEF 158158
11 XBRL LABEL FILE prph-20180630_lab.xml EX-101.LAB 338706
12 XBRL PRESENTATION FILE prph-20180630_pre.xml EX-101.PRE 237194
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 181028821
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1